Oculis Holding AG OCS
NASDAQ OCS
$12.20 +0.03 (+0.25%)
As of: Sep 4, 2026 · 3:20 PM EDT

Oculis Holding AG (OCS) Profit After Tax (2022 - 2026)

Oculis Holding AG (OCS) posted quarterly Profit After Tax of -$36.8 million for Q1 2026, little changed year-over-year from -$36.7 million in Q1 2025, and down 25.23% quarter-over-quarter from -$29.4 million in Q4 2025.

Analysis

Oculis Holding AG (OCS) Profit After Tax (2022 - 2026) Analysis & Trends

Oculis Holding AG's Profit After Tax history runs 5 years deep, the most recent figure standing at -$36.8 million for Q1 2026.

  • In Q1 2026, Profit After Tax changed 0.26% year-over-year to -$36.8 million; the TTM figure through Mar 2026 stood at -$21.2 billion (up 9.53% YoY), while the FY2025 annual figure was -$119.4 million, down 22.41% from the prior year.
  • Profit After Tax for Q1 2026 stood at -$36.8 million, down from -$29.4 million in the prior quarter.
  • The five-year high for Profit After Tax was -$9.5 million in Q4 2022, with the low at -$23.3 billion in Q3 2024.
  • The 5-year median for Profit After Tax is -$26.2 million (2025), against an average of -$2.8 billion.
  • Peak annual rise in Profit After Tax reached 62.94% in 2024, while the deepest fall reached 118106.55% in 2024.
  • Oculis Holding AG's Profit After Tax stood at -$9.5 million in 2022, then slumped by 47.82% to -$14.1 million in 2023, then plunged by 132.14% to -$32.7 million in 2024, then increased by 10.06% to -$29.4 million in 2025, then retreated by 25.23% to -$36.8 million in 2026.
  • Business Quant data shows OCS's Profit After Tax at -$36.8 million in Q1 2026, -$29.4 million in Q4 2025, and -$21.1 billion in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn 472.00 Mn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn - -644.37 Mn
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 81.49 Mn
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn -16.62 Mn
10 Oculis Holding AG 635.01 Mn 346.13 Mn - -12.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -12.61 Mn
Mar 31, 2026 -36.84 Mn
Dec 31, 2025 -29.42 Mn
Sep 30, 2025 -21.07 Mn
Jun 30, 2025 -30.65 Mn
Mar 31, 2025 -36.94 Mn
Dec 31, 2024 -32.71 Mn
Sep 30, 2024 -23.30 Mn
Jun 30, 2024 -23.04 Mn
Mar 31, 2024 -18.44 Mn
Dec 31, 2023 -14.09 Mn
Sep 30, 2023 -19.71 Mn
Jun 30, 2023 -14.32 Mn
Mar 31, 2023 -49.75 Mn
Dec 31, 2022 -9.53 Mn
Sep 30, 2022 -10.31 Mn
Jun 30, 2022 -12.82 Mn